← Back to headlines
Eli Lilly Expands Pipeline with Positive Trial Data and New Licensing Deal
Eli Lilly (LLY) has announced the expansion of its pharmaceutical pipeline, driven by positive trial data and a new licensing agreement.
23 Feb, 19:51 — 23 Feb, 19:51
Sources
Showing 1 of 1 sources
Related Stories
Pathologist Shares Four Simple Rules for Weight Loss
37m ago
British Actress Nikki Sanderson Reveals Abuse Over Pregnancy in Her Forties
41m ago
Son of Blind College Football Player Completes Treatment for Rare Eye Cancer
45m ago
Study Suggests Syphilis-Like Disease Spread in Ancient Vietnam, Challenging Columbus Theory
46m ago